trending Market Intelligence /marketintelligence/en/news-insights/trending/quf_aqdsven9lsdknmv5tq2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Tandem Diabetes closes $115M common stock offering

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Tandem Diabetes closes $115M common stock offering

Tandem Diabetes Care Inc. closed a common stock offering to raise about $115 million in gross proceeds, the company said in an Aug. 7 press release.

The San Diego-based medical-device maker offered 3,508,770 common shares at $28.50 apiece. In addition, the underwriters fully exercised an option to buy an additional 526,315 shares.

Oppenheimer & Co. Inc. acted as the sole book-running manager, while Robert W. Baird & Co. Inc. acted as a co-manager for the offering.